|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
$800
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
$3,910
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
VEGF Function in B-CLL
|
5R01CA116237-02
|
$263,509
|
$131,755
|
KAY, NEIL
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
VCU Minority-Based CCOP
|
3U10CA052784-17S1
|
$100,000
|
$1,000
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based CCOP
|
5U10CA052784-17
|
$527,332
|
$5,273
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Utilizing Glycosyltransferases for Bioconjugation
|
Z01 BC 010742
|
$204,380
|
$61,314
|
Qasba, Pradman
|
CCR (NCI)
|
|
UT M.D. Anderson Cancer Center SPORE in Melanoma
|
3P50CA093459-04S1
|
$61,594
|
$15,399
|
GRIMM, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UT M.D. Anderson Cancer Center SPORE in Melanoma
|
5P50CA093459-04
|
$2,158,606
|
$539,652
|
GRIMM, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-23
|
$1,740,827
|
$17,408
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
University of Rochester Cancer Center CCOP Research Base
|
3U10CA037420-23S1
|
$146,724
|
$7,336
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-23
|
$1,131,018
|
$56,551
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Colorado Southwest Oncology Group
|
2U10CA042777-20
|
$82,102
|
$4,105
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
University of Colorado Southwest Oncology Group
|
3U10CA042777-20S1
|
$356,613
|
$17,831
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
U10 Ful Member Application Affiliated with SWOG
|
5U10CA105409-04
|
$229,230
|
$11,462
|
LIPPMAN, SCOTT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
5P01CA044991-20
|
$1,865,350
|
$1,119,210
|
Press, Oliver
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Therapeutic Studies of Primary CNS Malignancies-NABTT
|
5U01CA105706-04
|
$70,244
|
$702
|
BARNETT, GENE
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Therapeutic Studies of Anaplastic Gliomas (John Hopkins*
|
5U01CA076607-09
|
$115,818
|
$1,158
|
NABORS, LOUIS
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
The Pacific Northwest Prostate Cancer SPORE
|
2P50CA097186-06
|
$2,360,341
|
$472,068
|
NELSON, PETER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The molecular recognition of proteins by antibodies: A model for rational design
|
Z01 BC 010623
|
$468,090
|
$468,090
|
Smith-Gill, Sandra
|
CCR (NCI)
|
|
The Immunobiology of Marrow Allografts for Leukemia
|
2P01CA023766-29
|
$2,005,952
|
$401,190
|
O'REILLY, RICHARD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
The Immunobiology of Marrow Allografts for Leukemia
|
3P01CA023766-28S1
|
$872,075
|
$174,415
|
O'REILLY, RICHARD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
The Gulf Coast MBCCOP
|
1U10CA128536-01
|
$400,000
|
$4,000
|
SCHWARZENBERGER, PAUL
|
SACRED HEART HEALTH SYSTEMS, INC.
|
|
The Biological Basis of Breast Density and Cancer Risk
|
5P01CA107584-02
|
$1,369,207
|
$342,302
|
TLSTY, THEA
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
TGF-betas in breast cancer progression
|
Z01 BC 005785
|
$600,688
|
$240,275
|
Wakefield, Lalage
|
CCR (NCI)
|
|
Targeting Tumor Angiogenesis with SAHA and Bevacizumab in Kidney Cancer
|
1R21CA121590-01A2
|
$249,090
|
$124,545
|
Pili, Roberto
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeted Therapy of B-cell Malignancies
|
5P01CA103985-03
|
$1,603,282
|
$400,821
|
GOLDENBERG, DAVID
|
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY
|
|
Targeted Molecular Therapeutics for Melanoma: CCI-779 and Bevacizumab
|
1R21CA128367-01
|
$303,751
|
$303,751
|
SLINGLUFF, CRAIG
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Targeted antigen receptor treatment of cancer
|
5P01CA033049-24
|
$2,150,453
|
$2,150,453
|
HOUGHTON, ALAN
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Studies of Proteins with Important Roles in Immunology and/or Cancer Biology
|
Z01 BC 010761
|
$77,793
|
$15,559
|
Lubkowski, Jacek
|
CCR (NCI)
|
|
ST Louis-Cape Girardeau CCOP
|
2U10CA035128-24
|
$440,482
|
$4,405
|
Sleckman, Bethany
|
ST. JOHN'S MERCY MEDICAL CENTER
|
|
SPORE in Pancreatic Cancer
|
5P20CA101955-05
|
$855,582
|
$171,116
|
BUCHSBAUM, DONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
SPORE in Gl Cancer
|
2P50CA095103-06
|
$2,278,307
|
$569,577
|
COFFEY, ROBERT
|
VANDERBILT UNIVERSITY
|
|
SPORE in Brain Cancer
|
3P50CA108786-04S1
|
$146,300
|
$36,575
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
SPORE in Brain Cancer
|
5P50CA108786-04
|
$50,001
|
$12,500
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
Southwest Oncology Group/ University of California,
|
3U10CA046441-20S1
|
$25,000
|
$1,250
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Southwest Oncology Group/ University of California,
|
5U10CA046441-20
|
$344,197
|
$17,210
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Southwest Oncology Group Statistical Center
|
5U10CA038926-22
|
$4,612,382
|
$230,619
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-28S2
|
$159,600
|
$7,980
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
3U10CA032102-28S3
|
$316,222
|
$15,811
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-28
|
$9,423,958
|
$471,198
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group
|
2U10CA004919-48
|
$192,303
|
$9,615
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Southwest Oncology Group
|
3U10CA004919-48S1
|
$25,000
|
$1,250
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Southwest Oncology Group
|
3U10CA046282-20S1
|
$43,000
|
$2,150
|
STIFF, PATRICK
|
LOYOLA UNIVERSITY CHICAGO
|
|
Southwest Oncology Group
|
5U10CA046282-20
|
$425,510
|
$21,276
|
STIFF, PATRICK
|
LOYOLA UNIVERSITY CHICAGO
|
|
Southwest Oncology Group
|
3U10CA020319-31S1
|
$32,199
|
$1,610
|
RIVKIN, SAUL
|
SWEDISH MEDICAL CENTER, FIRST HILL
|
|
Southwest Oncology Group
|
5U10CA020319-31
|
$341,152
|
$17,058
|
RIVKIN, SAUL
|
SWEDISH MEDICAL CENTER, FIRST HILL
|
|
SOUTHWEST ONCOLOGY GROUP
|
3U10CA013612-34S1
|
$20,000
|
$1,000
|
MILLER, THOMAS
|
UNIVERSITY OF ARIZONA
|
|
SOUTHWEST ONCOLOGY GROUP
|
5U10CA013612-34
|
$266,362
|
$13,318
|
MILLER, THOMAS
|
UNIVERSITY OF ARIZONA
|
|
Southwest Oncology Group
|
2U10CA027057-28
|
$255,214
|
$12,761
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group
|
3U10CA027057-28S1
|
$43,000
|
$2,150
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
Total relevant funding to MOAB for this search: $38,044,563
|